Track the Expres2ion Biotech Holding AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Expres2ion Biotech Holding AB has recorded 9 public disclosures. Market capitalisation: €13.9m. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: Bent Frandsen. Every trade is free.
9
Insider Decl.
n/a
Thresholds
€38,078
6 ops.
Buy Volume
€61,987
2 ops.
Sell Volume
41Σ signal
Buys €38,078€61,987 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
15,000 shares@ SEK 42.00100.0% of flowAktieISINISIN SE0008348262FI:A001R218-1
9 of 9 declarations
About Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB is a company focused on developing biopharmaceutical solutions. It specializes in the production of recombinant proteins for therapeutic applications.